Adaptive Biotechnologies ADPT Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Adaptive Biotechnologies’s reported figures.
The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Adaptive Biotechnologies's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Adaptive Biotechnologies's enterprise value?
- Adaptive Biotechnologies (ADPT) reported enterprise value of $2.27B in Q1 2026.
- How has Adaptive Biotechnologies's enterprise value changed year-over-year?
- Adaptive Biotechnologies's enterprise value increased by 78.0% year-over-year, from $1.27B to $2.27B.
- What is the long-term trend for Adaptive Biotechnologies's enterprise value?
- Over 5 years (2020 to 2025), Adaptive Biotechnologies's enterprise value has grown at a -20.7% compound annual growth rate (CAGR), from $8.33B to $2.62B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.